Search results for: 'Advances in Gene Editing'

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...

The field of predictive analytics is one of the most complex and challenging subsets of the Big Data and advanced analytic market. There is also a very wide gap between the practitioners of predictive analyticsmost of whom are statisticians, scientific researchers and data scientistsand the people who most want to use predictive analytics for com...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

Advanced visualization and robotic tools during the pre-operative and intraoperative phases of a procedure allow surgeons to identify and localize targets so that they can navigate and perform complex surgeries with precision, minimizing invasiveness, improving recovery times, and lowering the risk of post-procedure complications. This Frost & ...

This edition of Trend Opportunity Profiles features trend advancements in health, wellness, and nutrition featuring sensors for food products or pharmaceutical drugs, sustainable nutrition, technology-induced healthcare including AI for drug discovery and blockchain for data intelligence, personalized health solutions, online consultations, behavio...

Global two-wheeler markets are transitioning from internal combustion engine (ICE) two-wheelers to electric two-wheelers. In that context, the design and development of software-defined platforms are crucial for OEMs. Furthermore, consumers are becoming deeply knowledgeable about vehicle specifications thanks to the influence of online social media...